Greenwich Lifesciences Inc
(GLSI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,436 | -7,284 | -3,258 | -15,789 | -7,749 |
| Depreciation Amortization | 2 | 2 | 1 | 4 | 3 |
| Accounts payable and accrued liabilities | -69 | 119 | -130 | 921 | 518 |
| Other Working Capital | 62 | 126 | -121 | 1,265 | 548 |
| Other Operating Activity | 4,701 | 2,969 | 1,674 | 6,332 | 1,265 |
| Operating Cash Flow | $-6,739 | $-4,068 | $-1,835 | $-7,267 | $-5,414 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 6,454 | 3,101 | 492 | 4,369 | 4,247 |
| Financing Cash Flow | $6,454 | $3,101 | $492 | $4,369 | $4,247 |
| Beginning Cash Position | 4,092 | 4,092 | 4,092 | 6,989 | 6,989 |
| End Cash Position | 3,807 | 3,125 | 2,750 | 4,092 | 5,822 |
| Net Cash Flow | $-285 | $-967 | $-1,342 | $-2,897 | $-1,167 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,739 | -4,068 | -1,835 | -7,267 | -5,414 |
| Free Cash Flow | -6,739 | -4,068 | -1,835 | -7,267 | -5,414 |